Date | Price Target | Rating | Analyst |
---|---|---|---|
12/20/2023 | $5.00 | Buy | ROTH MKM |
4/8/2022 | $9.00 | Buy | Lake Street |
3/11/2022 | $35.00 → $32.00 | Outperform | RBC Capital |
11/11/2021 | $34.00 → $35.00 | Outperform | RBC Capital |
7/9/2021 | $31.00 | Outperform | RBC Capital |
SC 13G/A - Forian Inc. (0001829280) (Subject)
SC 13G/A - Forian Inc. (0001829280) (Subject)
SC 13G - Forian Inc. (0001829280) (Subject)
4 - Forian Inc. (0001829280) (Issuer)
4 - Forian Inc. (0001829280) (Issuer)
4 - Forian Inc. (0001829280) (Issuer)
10-Q - Forian Inc. (0001829280) (Filer)
8-K - Forian Inc. (0001829280) (Filer)
8-K - Forian Inc. (0001829280) (Filer)
NEWTOWN, Pa., Sept. 1, 2021 /PRNewswire/ -- Forian Inc. (NASDAQ:FORA), a provider of technology, analytics and data science driven solutions for the healthcare and cannabis industries, today announced the following: Convertible Notes Offering The Company has entered into a convertible note purchase agreement (the "Note Purchase Agreement") with a select group of institutional and accredited investors pursuant to which the Company will issue $24,000,000 aggregate principal amount at 100% of par value of its 3.5% convertible notes due 2025 (the "Notes"). The Notes are convertib
NEWTOWN, PA, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Forian Inc. (NASDAQ:FORA), a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, today announced results for the quarter ended June 30, 2024. "We continued to invest in our information assets in the second quarter to further differentiate our offerings and the insights they power for our customers. We remain confident that our combination of thoughtful productization, diversification of data sources and prudent cost containment put us in solid position to manage through recent industry challenges and to continue our contribution to our customers' success," stated Max
NEWTOWN, PA , Aug. 02, 2024 (GLOBE NEWSWIRE) -- Forian Inc. (NASDAQ:FORA), a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, will announce its second quarter 2024 financial results on Wednesday, August 14, 2024, after the close of the market. The Company will host a conference call and webcast at 4:30 p.m. (ET) on August 14, 2024 to discuss the results. To register for the conference call, click here. The webcast will be available live at https://edge.media-server.com/mmc/p/c5ot6k5y This information is also available on our website at www.forian.com/investors. The earnings release along with a replay of the call promptly
Full Year 2023 Revenue Grew 25% Full Year 2023 Adjusted EBITDA of $2.3MM NEWTOWN, PA, March 28, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Forian Inc. (NASDAQ:FORA), a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, today announced results for the quarter and year ended December 31, 2023. "Forian finished the year by executing against our quarterly plan and closed what was a transformational year," stated Max Wygod, Chairman and Chief Executive Officer of Forian. "In 2023, we successfully completed a major divestiture and refocused our business on healthcare and life sciences, continued revenue growt
NEWTOWN, PA, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Forian Inc. (NASDAQ:FORA), a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, today announced results for the quarter ended June 30, 2024. "We continued to invest in our information assets in the second quarter to further differentiate our offerings and the insights they power for our customers. We remain confident that our combination of thoughtful productization, diversification of data sources and prudent cost containment put us in solid position to manage through recent industry challenges and to continue our contribution to our customers' success," stated Max
NEWTOWN, PA , Aug. 02, 2024 (GLOBE NEWSWIRE) -- Forian Inc. (NASDAQ:FORA), a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, will announce its second quarter 2024 financial results on Wednesday, August 14, 2024, after the close of the market. The Company will host a conference call and webcast at 4:30 p.m. (ET) on August 14, 2024 to discuss the results. To register for the conference call, click here. The webcast will be available live at https://edge.media-server.com/mmc/p/c5ot6k5y This information is also available on our website at www.forian.com/investors. The earnings release along with a replay of the call promptly
Full Year 2023 Revenue Grew 25% Full Year 2023 Adjusted EBITDA of $2.3MM NEWTOWN, PA, March 28, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Forian Inc. (NASDAQ:FORA), a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, today announced results for the quarter and year ended December 31, 2023. "Forian finished the year by executing against our quarterly plan and closed what was a transformational year," stated Max Wygod, Chairman and Chief Executive Officer of Forian. "In 2023, we successfully completed a major divestiture and refocused our business on healthcare and life sciences, continued revenue growt
ROTH MKM initiated coverage of Forian with a rating of Buy and set a new price target of $5.00
Lake Street initiated coverage of Forian with a rating of Buy and set a new price target of $9.00
RBC Capital reiterated coverage of VerticalScope Holdings with a rating of Outperform and set a new price target of $32.00 from $35.00 previously
Forian (NASDAQ:FORA) reported quarterly losses of $(0.04) per share which missed the analyst consensus estimate of $(0.02) by 100 percent. This is a 50 percent increase over losses of $(0.08) per share from the same period last year. The company reported quarterly sales of $4.88 million which missed the analyst consensus estimate of $5.11 million by 4.56 percent. This is a 0.14 percent increase over sales of $4.87 million the same period last year.
Roth MKM analyst Richard Baldry reiterates Forian (NASDAQ:FORA) with a Buy and maintains $5 price target.
Forian (NASDAQ:FORA) reported its Q4 earnings results on Thursday, March 28, 2024 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Forian beat estimated earnings by 67.0%, reporting an EPS of $-0.01 versus an estimate of $-0.03. Revenue was down $2.54 million from the same period last year. Past Earnings Performance Last quarter the company beat on EPS by $0.19 which was followed by a 8.0% increase in the share price the next day. Here's a look at Forian's past performance: Quarter Q3 2023 Q2 2023 Q1 2023 Q4 2022 EPS Estimate -0.03 -0.05 -0.11 -0.15 EPS Actual 0.16 -0.03 -0.08 -0.11 Revenue Estimate 5.22M 5.10M 5.70M 7.10M Revenue Actual 5.35M 4.8
4 - Forian Inc. (0001829280) (Issuer)